HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Ueno Selected Research

Cisplatin (Platino)

10/2021Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).
10/2003O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma.
1/2000Selective beta2-adrenoceptor agonist enhances sensitivity to cisplatin in non-small cell lung cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Ueno Research Topics

Disease

19Neoplasms (Cancer)
10/2022 - 01/2000
11Hepatocellular Carcinoma (Hepatoma)
01/2021 - 02/2000
9Fibrosis (Cirrhosis)
10/2022 - 08/2000
9Infections
10/2019 - 01/2000
7Breast Neoplasms (Breast Cancer)
11/2013 - 07/2000
6Intestinal Failure
11/2018 - 07/2006
6Neoplasm Metastasis (Metastasis)
10/2006 - 06/2000
4Chronic Hepatitis C
10/2022 - 07/2001
3Lung Neoplasms (Lung Cancer)
10/2022 - 01/2000
3Body Weight (Weight, Body)
10/2021 - 02/2000
3Insulin Resistance
12/2014 - 03/2008
3Reperfusion Injury
02/2011 - 04/2000
3Osteoporosis
08/2010 - 01/2004
3Atherosclerosis
01/2007 - 12/2000
2Autoimmune Diseases (Autoimmune Disease)
10/2022 - 12/2001
2Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 03/2004
2Hypertension (High Blood Pressure)
11/2018 - 10/2018
2Communicable Diseases (Infectious Diseases)
10/2018 - 03/2002
2Biliary Atresia
05/2016 - 01/2016
2Diabetic Nephropathies (Diabetic Nephropathy)
04/2015 - 12/2004
2Spinal Cord Injuries (Spinal Cord Injury)
07/2012 - 03/2011
2Inflammation (Inflammations)
06/2011 - 02/2010
2Thrombosis (Thrombus)
10/2010 - 11/2001
2Bone Resorption
08/2010 - 03/2004
2Carcinogenesis
05/2007 - 09/2000
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2007 - 01/2000
2Lymphoproliferative Disorders (Lymphoproliferative Disorder)
07/2006 - 07/2006
2Melanoma (Melanoma, Malignant)
10/2003 - 12/2000
2Oral Lichen Planus
03/2002 - 07/2000
2Ischemia
10/2001 - 02/2001
2Myocardial Infarction
06/2001 - 06/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
01/2001 - 04/2000
2Chest Pain (Chest Pains)
10/2000 - 08/2000
2Shock
08/2000 - 01/2000
2Liver Cirrhosis (Hepatic Cirrhosis)
08/2000 - 02/2000
2Mouth Neoplasms (Oral Cancer)
07/2000 - 03/2000
2Carcinoma (Carcinomatosis)
05/2000 - 03/2000
2Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
02/2000 - 01/2000
1Rheumatoid Arthritis
10/2022
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
10/2022

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
10/2022 - 08/2000
5Peptides (Polypeptides)IBA
12/2001 - 03/2000
4Docetaxel (Taxotere)FDA Link
10/2021 - 06/2004
4AntibodiesIBA
11/2016 - 01/2000
4CytokinesIBA
03/2004 - 06/2000
3Insulin (Novolin)FDA Link
10/2022 - 04/2001
3Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2000
3Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 06/2004
3LipidsIBA
10/2018 - 12/2014
3Biomarkers (Surrogate Marker)IBA
11/2013 - 03/2011
3Immunosuppressive Agents (Immunosuppressants)IBA
08/2010 - 01/2004
3PPAR gammaIBA
03/2008 - 05/2001
3Immunoglobulin G (IgG)IBA
01/2007 - 01/2000
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2006 - 08/2000
3RNA (Ribonucleic Acid)IBA
03/2004 - 07/2000
2AlbuminsIBA
10/2022 - 01/2021
2C-Reactive ProteinIBA
10/2021 - 12/2006
2asunaprevirIBA
10/2019 - 11/2016
2daclatasvirIBA
10/2019 - 11/2016
2Dihydrotachysterol (AT 10)IBA
11/2018 - 09/2012
2Calcineurin InhibitorsIBA
10/2018 - 04/2016
2Anti-Bacterial Agents (Antibiotics)IBA
07/2015 - 06/2000
2Capecitabine (Xeloda)FDA Link
11/2013 - 06/2004
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 06/2004
2Epirubicin (Ellence)FDA LinkGeneric
11/2013 - 06/2004
2NF-kappa B (NF-kB)IBA
08/2013 - 10/2001
2Oncogene Proteins (Oncogene Protein)IBA
08/2013 - 07/2006
2OsteoprotegerinIBA
06/2011 - 03/2004
2Tacrolimus (Prograf)FDA LinkGeneric
08/2010 - 03/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
02/2010 - 07/2006
2Advanced Glycation End ProductsIBA
09/2008 - 03/2008
2Serine (L-Serine)FDA Link
09/2008 - 03/2008
2Telmisartan (Micardis)FDA Link
03/2008 - 12/2006
2AutoantibodiesIBA
01/2007 - 01/2000
2Immunoglobulin M (IgM)IBA
01/2007 - 03/2002
2Dimethylnitrosamine (Nitrosodimethylamine)IBA
03/2005 - 08/2000
2Thymidine PhosphorylaseIBA
06/2004 - 08/2000
2Messenger RNA (mRNA)IBA
03/2004 - 10/2001
2ImmunosorbentsIBA
04/2003 - 07/2000
2EnzymesIBA
04/2003 - 07/2000
2Anticardiolipin AntibodiesIBA
03/2002 - 01/2000
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2001 - 08/2000
2IntegrinsIBA
08/2001 - 07/2001
2Collagen Type IV (Type IV Collagen)IBA
08/2001 - 07/2001
2Hyaluronic Acid (Hyaluronan)IBA
07/2001 - 08/2000
2InterferonsIBA
07/2001 - 10/2000
2Hypoglycemic Agents (Hypoglycemics)IBA
04/2001 - 06/2000
2human neutrophil peptide 1IBA
07/2000 - 03/2000
1Antiviral Agents (Antivirals)IBA
10/2022
1Vitamin KFDA Link
10/2022
1BilirubinIBA
10/2022
1Prealbumin (Transthyretin)IBA
10/2021

Therapy/Procedure

14Therapeutics
10/2022 - 01/2000
13Transplantation
11/2018 - 02/2001
6Liver Transplantation
11/2018 - 01/2016
5Drug Therapy (Chemotherapy)
10/2021 - 01/2000
3Catheters
01/2017 - 10/2001
2Parenteral Nutrition
07/2014 - 06/2013
2Neoadjuvant Therapy
11/2013 - 06/2004
2Aftercare (After-Treatment)
06/2000 - 02/2000